Rite Aid Corp (RAD.N)
11 Dec 2017
Discount store operator Fred's Inc said on Wednesday it had canceled its quarterly cash dividend and was exploring alternatives for some of its assets, sending its shares plunging 25 percent to their lowest in more than 18 years.
WASHINGTON It is uncertain who in the U.S. government will carry out an antitrust review of CVS Health Corp's deal to buy health insurer Aetna Inc , but the drugstore company is likely hoping the potentially more lenient Federal Trade Commission gets the nod, antitrust experts say. | Video
(The following statement was released by the rating agency) NEW YORK, December 05 (Fitch) Fitch Ratings has assigned an 'A-' rating to AmerisourceBergen's (ABC) sale of $750 million senior notes due 2027 and $500 million senior notes due 2047. Proceeds are expected to be used to finance the acquisition of H.D. Smith for $815 million in cash and to redeem 4.875% senior notes due Nov. 15, 2019, and for general corporate purposes. See key terms of the notes below the list of rating actions. Fitch h
(The following statement was released by the rating agency) NEW YORK, December 05 (Fitch) Fitch Ratings has downgraded GNC Holdings, Inc.'s IDR to 'B-' from 'B' on increased refinancing risk following the announced withdrawal of its proposed refinancing offering. The Negative Outlook reflects Fitch's reduced confidence in GNC's ability to address upcoming maturities ($300 million revolver due September 2018 and $1.1 billion term loan maturity in March 2019) given the termination of its current r
WASHINGTON, Dec 5 It is uncertain who in the U.S. government will carry out an antitrust review of CVS Health Corp's deal to buy health insurer Aetna Inc, but the drugstore company is likely hoping the potentially more lenient Federal Trade Commission gets the nod, antitrust experts say.
* RITE AID ANNOUNCES FIRST CLOSINGS OF ASSET SALE TO WALGREENS BOOTS ALLIANCE Source text for Eikon: Further company coverage:
* Rite Aid announces senior management changes in category management
AmerisourceBergen Corp said it expects stubbornly low generic drug prices, which have plagued drugmakers and wholesalers, to not deteriorate further next year, and brushed off concerns about Amazon's possible entry into the industry.
* Shares initially rise, before reversing course (Adds details on forecast, CEO and analyst comments; updates shares)
BRIEF-AmerisourceBergen, on conf call, says current trends indicate that generic buy side deflation rate has not worsened
* AmerisourceBergen CEO, on conf call, says an aging U.S. patient population continues to "demand" the support of pharmaceutical intervention